News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
Presentation TVT 2019 Don’t Stop The Warfarin!: A Case of Left Atrial Appendage Closure Device Thrombus Presenter: Siri Kadire June 13, 2019
Presentation TVT 2019 Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation Presenter: DJ Lakkireddy June 13, 2019
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
Presentation TVT 2013 "New" Anticoagulation Options for A-fib: Beyond Warfarin Presenter: Michael Ezekowitz June 15, 2013
Presentation TVT 2012 The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions Presenter: Saibal Kar June 05, 2012
Presentation TVT 2012 ASAP Results: The Watchman in Warfarin Ineligible Patients Presenter: Shephal Doshi June 05, 2012